Tag: UK Pharma

Novartis Statement Regarding No-Deal Brexit

Novartis has issued a statement expressing concern over the state of medicine supply to the UK, and noting that it is building increased inventories across its portfolio of medicines in the UK. The...

Destiny Pharma Got £1.6m to Examine XF Drugs for Superbugs

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, that addresses the global problem of antimicrobial resistance (AMR), today announces it ...

No-Deal Brexit – Guidance for Clinical Trials

The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) released further guidance on the regulation of medicines, medical devices and clinical trials if there is no Brexit deal. The scenar...

UK Breakthrough Plan for AMR

A new reimbursement model for antibiotics by the NHS and NICE is being labelled as a ‘great breakthrough’. The model is part of the government’s new national action plan on how it will fight agains...

Almac Expands Facility for Personalised Cancer Vaccine

Contract development and manufacturing organisation (CDMO) The Almac Group has announced it is expanding its Edinburgh Technopole facility to help scale-up its personalised cancer vaccine activities. ...

New MMIC in Scotland

A new research, development and manufacturing facility for medicines is to be built in Scotland thanks to a partnership between the Centre for Process Innovation (CPI) and multiple partners. The Me...

UK Researcher to Fight Opioid Addiction

A UK university has been awarded £2.4 million to research overprescribing of opioids, and how to improve treatment of patients with persistent pain without long-term use of these morphine-like drugs. ...

RPS Introduced Professional Standards for Community Pharmacists

The Royal Pharmaceutical Society has begun to produce its first ever ‘Professional Standards for Community Pharmacy Services’. A consultation has begun to determine the standards that will set out ...

Paediatric Licence for Asthma Drug

The European Medicines Agency (EMA) has approved Flutiform pMDI for use in the treatment of children with asthma aged five years and over. Flutiform pMDI is a combination of fluticasone propionate ...

UK and Japan Cooperate for Severe Diseases Treatment

Medical researchers in the UK and Japan are to join forces in the fight to advance research into treatments for some of the most debilitating degenerative diseases such as diabetes, heart disease and ...

UK Signs Contracts for Drug Storage in “no-deal” Brexit

Officials hope third contract for warehousing will be signed shortly, with total cost of £10m. The government has signed two contracts to secure warehouse space for the storage of drugs as part of ...

MHRA Approved Upperton New Facilities

Spray drying specialist has invested in building enhancements and in the expansion of its processing and analytical capabilities The UK Medicines and Healthcare products Regulatory Agency (MHRA) ha...

NICE Rejects Novartis Drug

Some migraine sufferers in the UK hoping to get access to Novartis’ new migraine prevention drug Aimovig are facing disappointment after NICE rejected it in draft guidance. The cost-effectiveness w...

First Details of NHS Long Term Plan

Long-awaited details of the NHS Long Term Plan - which is to be funded by a government investment of £20.5 billion a year in real terms by 2023/24 and aims to transform patient care while spending tax...

Potential Pitfalls of Brexit for Pharma

With less than 4 months remaining before the UK is scheduled to leave the EU in what is commonly referred to as “Brexit”, concerns are increasing within the pharmaceutical industry about the consequen...

Intract Gets Grant for Developing Novel Antibody Products

Drug delivery developer Intract Pharma has been awarded a £1.4 million grant by Innovate UK to develop a scalable manufacturing process for novel oral antibody products. The company will develop a ...